WHO ICTRP trial
The role of levamisole co-administration hepatitis B vaccine in immunization.
IRCT2014110618915N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2014110618915N2 |
|---|---|
| Public title | The role of levamisole co-administration hepatitis B vaccine in immunization. |
| Scientific title | The effect of levamisole co-administration on the level of immune response to hepatitis B vaccine in healthy individuals. |
| Primary sponsor | Mashad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Need for immunization against viral hepatitis. Persons with potential health hazards related to communicable diseases;Persons with potential health hazards related to communicable diseases |
| Interventions | Intervention 1: Placebo: administered orally from one week prior to every hepatitis-B vaccination dose to one week after. Intervention 2: Intervention: levamisole administered orally from one week prior to every hepatitis-B vaccination dose… |
| Registration date | Nov 19, 2014 |
| Target size | 217 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: